Holen Sie sich die Stockscreener-App
6.35
3.08%
0.19
Handel nachbörslich:
6.37
0.02
+0.31%
Schlusskurs vom Vortag:
$6.16
Offen:
$6.2
24-Stunden-Volumen:
6.73M
Relative Volume:
1.07
Marktkapitalisierung:
$1.13B
Einnahmen:
$2.54B
Nettoeinkommen (Verlust:
$-207.36M
KGV:
-5.3361
EPS:
-1.19
Netto-Cashflow:
$151.25M
1W Leistung:
-2.76%
1M Leistung:
-12.53%
6M Leistung:
-24.58%
1J Leistung:
-35.73%
1-Tages-Spanne:
$6.15
$6.40
1-Wochen-Bereich:
$6.03
$6.51
52-Wochen-Spanne:
$6.03
$15.21
Teladoc Health Inc Stock (TDOC) Company Profile
Firmenname
Teladoc Health Inc
Sektor
Branche
Telefon
(203) 635-2002
Adresse
155 E 44TH STREET, NEW YORK, NY
Vergleichen Sie TDOC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
6.35 | 1.09B | 2.54B | -207.36M | 151.25M | -1.19 |
|
VEEV
Veeva Systems Inc
|
225.28 | 36.12B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
68.36 | 11.62B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
40.80 | 7.50B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
86.42 | 7.23B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
39.60 | 7.08B | 11.99B | 24.18M | 234.31M | 0.2956 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Equal Weight |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-07-25 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Bestätigt | Jefferies | Hold |
| 2024-02-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-17 | Herabstufung | DA Davidson | Buy → Neutral |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-02-23 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Hochstufung | Guggenheim | Sell → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-17 | Herabstufung | Guggenheim | Neutral → Sell |
| 2022-08-12 | Eingeleitet | DA Davidson | Buy |
| 2022-08-02 | Herabstufung | Berenberg | Buy → Hold |
| 2022-08-02 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-07-28 | Herabstufung | Goldman | Buy → Neutral |
| 2022-07-28 | Herabstufung | Needham | Buy → Hold |
| 2022-07-06 | Bestätigt | BofA Securities | Neutral |
| 2022-05-05 | Herabstufung | Argus | Buy → Hold |
| 2022-04-28 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-28 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-04-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-03 | Hochstufung | Argus | Hold → Buy |
| 2022-02-23 | Bestätigt | BofA Securities | Neutral |
| 2022-02-23 | Bestätigt | Craig Hallum | Hold |
| 2022-02-23 | Bestätigt | Evercore ISI | In-line |
| 2022-02-23 | Bestätigt | Goldman | Buy |
| 2022-02-23 | Bestätigt | JP Morgan | Overweight |
| 2022-02-23 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Bestätigt | Needham | Buy |
| 2022-02-23 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2022-02-08 | Bestätigt | Piper Sandler | Overweight |
| 2021-12-02 | Fortgesetzt | Jefferies | Hold |
| 2021-11-22 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-28 | Bestätigt | Barclays | Equal Weight |
| 2021-10-28 | Bestätigt | BofA Securities | Neutral |
| 2021-10-28 | Bestätigt | Canaccord Genuity | Buy |
| 2021-10-28 | Bestätigt | Citigroup | Buy |
| 2021-10-28 | Bestätigt | Craig Hallum | Hold |
| 2021-10-28 | Bestätigt | Needham | Buy |
| 2021-10-28 | Bestätigt | Oppenheimer | Outperform |
| 2021-10-28 | Bestätigt | Piper Sandler | Overweight |
| 2021-10-28 | Bestätigt | UBS | Neutral |
| 2021-10-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-08-02 | Herabstufung | Argus | Buy → Hold |
| 2021-07-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Eingeleitet | Robert W. Baird | Neutral |
| 2021-04-15 | Eingeleitet | Needham | Buy |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-12-22 | Eingeleitet | Evercore ISI | In-line |
| 2020-12-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Eingeleitet | Goldman | Neutral |
| 2020-11-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Eingeleitet | DA Davidson | Buy |
| 2020-09-02 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-17 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-07-13 | Eingeleitet | Argus | Buy |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-04-30 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-03-31 | Herabstufung | Berenberg | Buy → Hold |
| 2020-03-25 | Herabstufung | Craig Hallum | Buy → Hold |
| 2020-03-16 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Eingeleitet | UBS | Neutral |
| 2020-01-09 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Teladoc Health Inc Aktie (TDOC) Neueste Nachrichten
Is Teladoc’s Expanded 24/7 Care Data Strategy a Durable Edge in Virtual Care Competition (TDOC)? - Yahoo Finance New Zealand
2 Beaten-Down Stocks That Could Sink Even More in 2026 - Finviz
Sarepta and Teladoc Face Major Challenges, Stock Outlook Dim - Intellectia AI
Sarepta Therapeutics and Teladoc Health Face Major Challenges, 2026 Outlook Dismal - Intellectia AI
2 Beaten-Down Stocks That Could Sink Even More in 2026 - The Motley Fool
Teladoc Health Sees Unusually Large Options Volume (NYSE:TDOC) - MarketBeat
Teladoc Health: Why Low Valuation Doesn't Equal A 'Buy' (Rating Downgrade) (NYSE:TDOC) - Seeking Alpha
Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD), Teladoc (TDOC) and Immunome (IMNM) - The Globe and Mail
Teladoc Health shares tumble for seven consecutive sessions - MSN
Teladoc Health (TDOC) Faces Decline Amid Analyst Optimism - GuruFocus
Teladoc Health (TDOC) Shares Drop for Seven Consecutive Sessions, Losing Nearly 16% - Intellectia AI
Teladoc and EverQuote Shares Plummet, What You Need To Know - Finviz
(TDOC) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
3 Reasons to Avoid TDOC and 1 Stock to Buy Instead - Finviz
Hims & Hers Expands Platform-Led Access to Digital Healthcare - The Globe and Mail
Analyst Downgrade: Can Teladoc Health Inc beat the S P 500Entry Point & Reliable Price Breakout Alerts - baoquankhu1.vn
Teladoc stock hits 52-week low at $6.34 By Investing.com - Investing.com Nigeria
Aug Movers: What is Teladoc Health Incs TAM Total Addressable MarketWeekly Profit Recap & Real-Time Market Trend Scan - baoquankhu1.vn
Teladoc Health (NYSE:TDOC) Reaches New 52-Week LowTime to Sell? - MarketBeat
Teladoc stock hits 52-week low at $6.34 - Investing.com
Lobbying Update: $60,000 of TELADOC HEALTH INC lobbying was just disclosed - Quiver Quantitative
Is Teladoc’s Data‑Driven 24/7 Care Upgrade Quietly Reframing Its Integrated Care Story (TDOC)? - Sahm
Teladoc Health 24 7 Care Upgrade Prompts Fresh Look At Apparent Valuation Discount - Sahm
Assessing Teladoc Health (TDOC) Valuation After Recent Share Price Volatility - Yahoo Finance
Retail Trends: Can Teladoc Health Inc beat the S P 5002025 Key Highlights & AI Powered Market Trend Analysis - baoquankhu1.vn
JPM 2026, Day 4: Clover predicts a profit, plans tech investments - Modern Healthcare
Teladoc (TDOC) Registers a Bigger Fall Than the Market: Important Facts to Note - sharewise.com
Aug Weekly: How Teladoc Health Inc stock reacts to bond yields2025 Stock Rankings & Fast Entry Momentum Alerts - moha.gov.vn
Teladoc Health, Inc. (TDOC) Stock Analysis: Navigating Challenges with a 25% Potential Upside - DirectorsTalk Interviews
Telemedicine Market to Reach US$ 488.89 Billion by 2033 at 16.8% - openPR.com
Reprint-MH25094TeledocHealth - Modern Healthcare
Teladoc Health Unveils New Capabilities to Treat More Conditions and Detect Care Gaps Earlier - MedCity News
Aug Swings: How volatile is Teladoc Health Inc stockMarket Growth Report & Expert Verified Movement Alerts - baoquankhu1.vn
Teladoc Health Unveils ‘Prism-Powered’ 24/7 Virtual Urgent Care for 100M Americans - HIT Consultant
Teladoc Health Inc: Best in Business 2025 - Modern Healthcare News
Barclays initiates coverage on Teladoc (TDOC) with equal weight at $8.50 - MSN
Teladoc Health Launches Enhanced 24/7 Care Service to Broaden Virtual Urgent Care Capabilities - Quiver Quantitative
Teladoc Health Launches Enhanced 24/7 Care Service - Bluefield Daily Telegraph
Teladoc Health, Inc. $TDOC Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat
Teladoc Health, Inc. (NYSE:TDOC) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Teladoc Health Buys Catapult Health In $65M Acquisition - MSN
Why Is Teladoc (TDOC) Down 14.8% Since Last Earnings Report? - MSN
Teladoc Health Inc. (TDOC) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Citigroup Lowers Target Price for Teladoc Health (TDOC) to $9.00 - GuruFocus
Citigroup Cuts Teladoc Health (NYSE:TDOC) Price Target to $9.00 - MarketBeat
(TDOC) Risk Channels and Responsive Allocation - Stock Traders Daily
Is Teladoc Health Inc. stock supported by free cash flowEarnings Summary Report & Long-Term Safe Investment Ideas - ulpravda.ru
Why Teladoc Health Inc. stock could benefit from AI revolutionPortfolio Profit Report & Expert-Curated Trade Recommendations - ulpravda.ru
Hims & Hers Plunges 39.2% in 3 Months: Time to Hold the Stock or Sell? - Finviz
Why Teladoc (TDOC) Dipped More Than Broader Market Today - sharewise.com
Can Teladoc (TDOC) Use AI And Partnerships To Offset BetterHelp Weakness And Competitive Pressure? - Yahoo Finance
Finanzdaten der Teladoc Health Inc-Aktie (TDOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.15%
2.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):